semaglutide and cardiovascular outcomes in obesity without diabetes SELECT Trial HUGE NEWS! Contrary to popular

Anti-obesity drugs should be offered as initial treatment of overweight and obesity for adults with weight-related comorbidities and for those at high risk of complications, and as a component of first-line treatment for patients with obesity and overweight without comorbidities

BMI 28-29: 5 mg

We present the case of a 66-year-old woman who developed weakness, nausea, and vomiting accompanied by markedly elevated creatine kinase levels after first t...

By Mrinalika Roy and Sriparna Roy April 20 (Reuters) - The surging popularity of GLP-1 weight-loss drugs is quietly reshaping the $40 billion U.S

These chemicals play key roles in attention and alertness

We make 100% natural supplements that are scientifically proven to help your skin, gut and mind.